Skip to content

Total Revenue at other companies

Opko Health logo
Opko HealthOPK
$124.2M-17.2%
AMP
Amphastar PharmaceuticalsAMPH
$171.17M+0.4%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$36.22M+77.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$17.7M+15.0%
HRO
HarrowHROW
$44.2M-7.6%
Precigen logo
PrecigenPGEN
$23.25M+1,634%

Segments

By segment

See full
Reportable Segment Aggregation Before Other Operating$58.3M+104%

By product

See full
Voquezna Product$58.3M+105%

Other financials

Income statement

See full
Gross profit$46.3M+86.8%
Operating income-$15.5M+80.4%
Net income-$30.4M+67.8%
EPS (diluted)-$0.37+71.8%

Balance sheet

See full
Cash & equivalents$180.9M-14.8%
Total debt$166.3M-18.3%
Total equity-$337.0M+0.4%
Total assets$305.1M+3.7%

Cash flow

See full
Operating cash flow-$15.6M+81.6%
CapEx$61.0K+239%
Free cash flow-$15.7M+81.5%

Valuation

See full
Market cap$846.21M+16.3%
Enterprise value$831.61M+15.7%
P/S4.1×-4.8×

Profitability

See full
Gross margin84.9%-1.3pp
Operating margin-47.1%-21.9pp
Net margin-76.8%-34.5pp
FCF margin-47.7%-22.1pp

Returns & leverage

See full
Return on equity-147.9%
Debt / equity5.6×
Current ratio2.2×-1.4×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s total revenue?
Phathom Pharmaceuticals, Inc. (PHAT) reported total revenue of $58.3M in Q1 2026.
How has Phathom Pharmaceuticals, Inc.'s total revenue changed year-over-year?
Phathom Pharmaceuticals, Inc.'s total revenue increased by 104.4% year-over-year, from $28.52M to $58.3M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.